HALO
#801
Halozyme Therapeutics, Inc. - Common Stock
110.7 8 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.02%
Variación mensual
+33.82%
Variación en los últimos 6 meses
+59.00%
Cambio anual
+65.84%
Cierres anteriores
109.6 6
Open
110.2 4
Mínimo
110.1 0
Máximo
110.8 3
Volumen
986
Financials
- Market Capitalization 12.57 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
22.89
Relación precio/flujo de caja
5.77
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 785 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 66.44 USD | -0.79% | +1.76% | +10.94% | +12.78% | 12.86 B USD | ||
| 798 |  MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 542.19 USD | -0.87% | -0.28% | +10.04% | +27.99% | 12.53 B USD | ||
| 809 |  CORT Corcept Therapeutics Incorporated - Common Stock | 112.83 USD | +2.17% | -3.51% | -0.15% | +53.78% | 12.20 B USD | ||
| 821 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 86.49 USD | +1.31% | -2.37% | -0.84% | +121.20% | 12.22 B USD |